NCT05675982View on ClinicalTrials.gov

Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells

NANot yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

January 2, 2025

Study Completion Date

January 2, 2026

Conditions

Diffuse Large B Cell Lymphoma

Interventions

OTHER

CAR-T cells monitoring

monitoring of circulating DNA by blood sample

Trial Locations (1)

Unknown

Centre Henri Becquerel, Rouen

All Listed Sponsors

lead

Centre Henri Becquerel

OTHER